Related Experiment Video
Updated: Mar 19, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Patient-reported outcome measures for allergy and asthma in children
Ireneous N Soyiri1, Bright I Nwaru1,2, Aziz Sheikh1
1Asthma UK Centre for Applied Research, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
Insights
Patient-reported outcome measures (PROMs) are vital for assessing pediatric allergies and asthma. While validated tools exist, more research is needed on their use in routine clinical care.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Outcomes Research
Background:
- Patient perceptions of disease and healthcare are increasingly recognized as crucial, comparable to traditional objective measures.
- Patient-reported outcome measures (PROMs) capture these subjective experiences, offering unique insights, especially for pediatric populations.
- For minors, both parental and child perspectives are vital, providing complementary information to objective assessments.
Purpose of the Study:
- To review and summarize existing evidence on patient-reported outcome measures (PROMs) for allergy and asthma in children.
- To identify validated pediatric PROMs for specific allergic conditions and asthma.
- To highlight the need for research on the implementation and utility of these PROMs in routine clinical practice.
Main Methods:
- Systematic review of literature on pediatric PROMs for allergy and asthma.
- Identification and evaluation of validated instruments for conditions including atopic eczema, food allergy, allergic rhinitis, and asthma.
- Assessment of evidence regarding the deployment of these PROMs outside of research settings.
Main Results:
- Fewer validated PROMs are available for pediatric use compared to adults.
- Validated pediatric PROMs were identified for atopic eczema/dermatitis, food allergy, allergic rhinitis/rhinoconjunctivitis, and asthma.
- Evidence on the use of these PROMs in routine clinical settings is very limited.
Conclusions:
- There is a pressing need to report on the experiences of using PROMs for pediatric allergy and asthma in routine clinical care.
- Further research should focus on the acceptability, integration into clinical workflows, and responsiveness of pediatric PROMs to treatment changes.
- Understanding these aspects is crucial for effectively incorporating PROMs into standard pediatric allergy and asthma management.
Abstract:
There is increasing recognition of the importance of patient's perceptions of disease and their assessments of heathcare processes. Patient-reported outcome measures (PROMs) are therefore now regarded as at least as important as the traditional objective measures of disease. For minors, parental and, except in the very young and severally cognitively impaired, the child's perspectives are important because they provide unique and complementary information. In this review, we summarize the evidence on PROMs for allergy and asthma for use in children. Overall, there are fewer PROMs available for use in children than in adults. We were able to identify some validated pediatric PROMs that have been developed for use in atopic eczema/dermatitis, food allergy, allergic rhinitis/rhinoconjunctivitis, and asthma. There is very limited evidence on deploying these instruments out with research settings. There is therefore a pressing need to report on the experiences of using PROMs for allergy and asthma in routine clinical care. In particular, there is a need to understand how acceptable these are to children/carers, whether they can be incorporated into routine clinical assessments and if they are responsive to changes in treatment made in routine clinical practice.
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

